Medicinal Products Availability

Dáil Éireann Debate, Friday - 7 September 2018

Friday, 7 September 2018

Questions (651, 655, 661, 667, 930)

Jack Chambers

Question:

651. Deputy Jack Chambers asked the Minister for Health further to Parliamentary Question No. 1445 of 24 July 2018, the definition of "timely fashion" with regard to the submission of a reimbursement application; the timeline for the application to be processed; if the process can be fast-tracked in view of the fact it is a second time application; if his attention has been drawn to the urgent nature of the application; and if he will make a statement on the matter. [35721/18]

Danny Healy-Rae

Question:

655. Deputy Danny Healy-Rae asked the Minister for Health if an application submitted by a company (details supplied) will be prioritised to ensure the availability of the drug Translarna; and if he will make a statement on the matter. [35730/18]

James Browne

Question:

661. Deputy James Browne asked the Minister for Health if a timeline will be provided for the consideration of an application for the drug Translarna by a company (details supplied); and if he will make a statement on the matter. [35740/18]

Catherine Murphy

Question:

667. Deputy Catherine Murphy asked the Minister for Health further to Parliamentary Question No. 482 of 12 July 2018, the length of time it takes the HSE to conduct a timely review with regard to the relevant statutory framework; and if he will make a statement on the matter. [35749/18]

Brendan Smith

Question:

930. Deputy Brendan Smith asked the Minister for Health his plans to make Translarna available through the HSE for young persons needing this particular medication in view of its availability in the UK and in 22 European countries; and if he will make a statement on the matter. [36762/18]

Written answers

Minister for Health

I propose to take Questions Nos. 651, 655, 661, 667 and 930 together.

The Health Service Executive has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013.

Accordingly, I have asked the HSE to reply to you directly.